Weaver, J. D., Stack, E. C., Buggé, J. A., Hu, C., McGrath, L., Mueller, A., Wong, M., Klebanov, B., Rahman, T., Kaufman, R., Fregeau, C., Spaulding, V., Priess, M., Legendre, K., Jaffe, S., Upadhyay, D., Singh, A., Xu, C., Krukenberg, K., Zhang, Y., Ezzyat, Y., Saddier Axe, D., Kuhne, M. R., Meehl, M. A., Shaffer, D. R., Weist, B. M., Wiederschain, D., Depis, F., & Gostissa, M. (2022). differential expression of CCR8 in tumors versus normal tissue allows specific depletion of tumor-infiltrating T regulatory cells by GS-1811, a novel Fc-optimized anti-CCR8 antibody. Oncoimmunology, 11, . http://access.bl.uk/ark:/81055/vdc_100169533755.0x000004